Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-01

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may be helpful in improving the efficiency and positioning of radiation oncology patients and their overall experience.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

NCT02782715

Carcinoma, Renal Cell

TERMINATED PHASE1/PHASE2

Development of Real-time Image-guided Radiotherapy

NCT03524248

Breast Cancer Lung Cancer Skin Cancer

TERMINATED NA

MRI Adaptive Replanning Using ViewRay

NCT02950792

Non-Small Cell Lung Cancer

WITHDRAWN NA

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

NCT05977322

Pancreatic Ductal Adenocarcinoma Gastroesophageal Adenocarcinoma Glioblastoma Multiforme

TERMINATED PHASE1

UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization

NCT05178927

Breast Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To obtain patient images in a clinical setting and assess their quality.

SECONDARY OBJECTIVES:

I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric.

OUTLINE:

Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial computed tomography (CT) simulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unspecified Adult Solid Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diagnostic (holographic mm-wave imaging)

Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial CT simulation.

Group Type EXPERIMENTAL

Millimeter-Wave Holographic Imaging

Intervention Type DEVICE

Undergo mm-wave holographic imaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Millimeter-Wave Holographic Imaging

Undergo mm-wave holographic imaging

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Holographic Millimeter-wave Imaging; Holographic mm-Wave Imaging; MMW Holographic Imaging; Millimeter-wave Imaging; MMW Imaging; MMW

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are scheduled to receive either an optical or CBCT imaging scan as part of their treatment management.
* The study will be open to English and Spanish speaking participants.